Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction.

Abstract

AimsDiuretic treatment is often needed in acute heart failure following myocardial infarction (MI) and carries a risk of abnormal potassium levels. We examined the relation between different levels of potassium and mortality.Methods and resultsFrom Danish national registries we identified 2596 patients treated with loop diuretics after their first MI episode where potassium measurement was available within 3 months. All-cause mortality was examined according to seven predefined potassium levels: hypokalaemia <3.5 mmol/L, low normal potassium 3.5–3.8 mmol/L, normal potassium 3.9–4.2 mmol/L, normal potassium 4.3–4.5 mmol/L, high normal potassium 4.6–5.0 mmol/L, mild hyperkalaemia 5.1–5.5 mmol/L, and severe hyperkalaemia: >5.5 mmol/L. Follow-up was 90 days and using normal potassium 3.9–4.2 mmol/L as a reference, we estimated the risk of death with a multivariable-adjusted Cox proportional hazard model. After 90 days, the mortality rates in the seven potassium intervals were 15.7, 13.6, 7.3, 8.1, 10.6, 15.5, and 38.3%, respectively. Multivariable-adjusted risk for death was statistically significant for patients with hypokalaemia [hazard ratio (HR): 1.91, confidence interval (95%CI): 1.14–3.19], and mild and severe hyperkalaemia (HR: 2, CI: 1.25–3.18 and HR: 5.6, CI: 3.38–9.29, respectively). Low and high normal potassium were also associated with increased mortality (HR: 1.84, CI: 1.23–2.76 and HR: 1.55, CI: 1.09–2.22, respectively).ConclusionPotassium levels outside the interval 3.9–4.5 mmol/L were associated with a substantial risk of death in patients requiring diuretic treatment after an MI.